Peter Radovich
Präsident bei MIRUM PHARMACEUTICALS, INC.
Vermögen: 815 909 $ am 30.04.2024
Aktive Positionen von Peter Radovich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Geschäftsführer | 28.04.2020 | - |
| Präsident | 16.01.2024 | - |
Karriereverlauf von Peter Radovich
Ehemalige bekannte Positionen von Peter Radovich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RAIN ONCOLOGY INC. | Direktor/Vorstandsmitglied | 01.03.2018 | 25.01.2024 |
| Independent Dir/Board Member | 01.03.2018 | 25.01.2024 | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Geschäftsführer | 01.09.2016 | 01.04.2020 |
| Corporate Officer/Principal | 01.11.2014 | 01.09.2016 | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Direktor/Vorstandsmitglied | 01.01.2004 | 01.09.2006 |
| Corporate Officer/Principal | 01.01.2004 | 01.09.2006 | |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01.01.2004 | 01.01.2006 |
Ausbildung von Peter Radovich
| University of Washington | Masters Business Admin |
| Texas Christian University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Director/Board Member | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
- Börse
- Insiders
- Peter Radovich
- Erfahrung
